NCT06056310 2025-09-29Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)EMD SeronoPhase 1 Terminated18 enrolled 9 charts
NCT03840902 2024-01-16M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)EMD SeronoPhase 2 Terminated153 enrolled 13 charts
NCT04529850 2022-08-16Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck CancerGalera Therapeutics, Inc.Phase 2 Completed38 enrolled 10 charts